Phathom Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -1.24M-109.30M-129.16M-141.83M-197.61M-201.40M-334.32M
Depreciation and Depletion 0.01M0.30M0.50M0.60M
Share-based Compensation 0.41M5.84M16.81M24.13M45.02M24.05M
Gains from Sales and Divestitures 0.10M1.01M0.97M
Gains from Investment Securities 96.27M1.50M-0.82M5.59M4.55M6.16M
Asset Writedowns and Impairment 0.84M
Non-cash Items 2.46M2.27M2.13M
Cash from Operations -1.02M-36.51M-69.69M-148.46M-146.53M-137.58M-266.77M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.41M1.27M3.60M3.48M3.58M3.77M
Depreciation & Amortization (CF) 0.01M0.32M0.52M0.62M0.57M0.80M
Change in Working Capital
Change in Receivables 1.64M37.16M
Change in Inventory 9.44M6.14M
Change in Accured Expenses 0.23M2.27M24.01M-9.79M8.68M6.41M34.94M
Other Working Capital Changes 0.02M11.81M-7.96M-0.60M1.86M8.07M7.67M
Investing Activities
Capital Expenditures 0.34M1.04M0.33M1.04M1.63M0.14M
Cash from Investing Activities -25.25M-1.04M-0.33M-1.04M-1.63M-0.14M
Financing Activities
Other financing activities 95.45M172.70M
Cash from Financing Activities 1.90M304.65M114.46M44.71M120.04M367.58M182.77M
Additional items
Change in Cash 0.88M242.89M43.73M-104.08M-27.53M228.37M-84.13M
Free Cash Flow -1.02M-36.85M-70.73M-148.78M-147.57M-139.21M-266.90M
Net Cash Flow 0.88M242.89M43.73M-104.08M-27.53M228.37M-84.13M